跳到正文
原文
MedPage Today·· 10 天前精选AI 评分85

左束支起搏在AVB患者中的优越性提前终止研究显示

Trial Stopped Early for Superiority of LBBP-Tuned Pacemakers

AI 导读

一项国际随机对照试验显示,左束支起搏(LBBP)在AVB患者中显著减少临床事件,优于右束支起搏(RVP),主要终点事件发生率分别为8.5%和19.2%。该研究由南京医科大学第一附属医院和华西医院的江钢博士领导,结果在AHA年会上公布。

推荐理由

该研究显示左束支起搏在AVB患者中的优越性,可能改变临床指南推荐。

正文

— LBBP preserved cardiac function and reduced events for people with AV block in randomized trial

by Nicole Lou, Senior Staff Writer, MedPage Today

November 9, 2026 • 4 min read

Left bundle branch pacing (LBBP) drastically reduced clinical events among patients with atrioventricular (AV) block, with results good enough to stop the OptimPacing trial early.

In that international randomized trial of patients getting permanent pacemakers with high ventricular pacing burden and a left ventricular ejection fraction (LVEF) >35%, LBBP bested right ventricular pacing (RVP) when it came to the primary endpoint of combined mortality, heart failure hospitalization, or pacing-induced cardiomyopathy at an interim 35.1-month analysis.

The 4-year estimated Kaplan-Meier event rates were 8.5% and 19.2%, respectively (HR 0.41, 95% CI 0.23-0.75), reported Jiangang Zou, MD, PhD, of First Affiliated Hospital, Nanjing Medical University, and Westchina Hospital in China. Individual outcomes were also reported for:

  • All-cause mortality: 7.4% with LBBP vs 7.7% with RVP
  • Heart failure hospitalization: 1.5% vs 2.9%
  • Pacing-induced cardiomyopathy: 0% vs 11.7%

Safety-wise, procedure- and pacing system-related complications reached 3.8% and 3.2% in the LBBP and RVP groups, and lead revision occurred in two patients each, Zou reported at the American Heart Association (AHA) annual meeting held in Chicago.

"LBBP demonstrated superiority over RVP in preserving cardiac function and reducing composite clinical outcomes for atrioventricular block," Zou said. "This study provides evidence supporting the consideration of LBBP as a first-line pacing strategy for patients with an anticipated high ventricular pacing requirement."

OptimPacing was simultaneously published in the New England Journal of Medicine.

LBBP is a type of conduction system pacing directly engaging the heart's intrinsic conduction system to preserve left ventricular electrical and mechanical synchrony. The result is typically a lower risk of pacing-induced cardiomyopathy -- compared with forced ventricular pacing -- hence LBBP becoming very popular in real-world practice.

"What we've learned here from this clinical trial, as we've learned when we buy a car or buy a house, is that location, location, location is very important," said Elaine Wan, MD, of Columbia University Medical Center in New York City, discussing the trial during a press conference.

LBBP in OptimPacing meant fixing a 3830 lumenless lead into the interventricular septum until the left ventricular subendocardium was reached, meeting prespecified LBBP criteria, whereas RVP meant a conventional active lead implanted in the right ventricular septum or apex using standard technique.

"Getting there and actually getting the effect, specifically the QRS that is similar to a physiological native QRS, is the goal, so not just parking it there, but actually getting the electrophysiological effect," Wan stressed. From OptimPacing's electrophysiological results of LBBP, "we get the most maintenance and sustainability of ejection fraction so far, since we've known for so long that forced ventricular pacing does not have any beneficial effect."

In 2023, the Heart Rhythm Society guidelines gave cardiac physiologic pacing a class IIa recommendation for patients with an LVEF 36-50% anticipated to require substantial ventricular pacing, and a weaker IIb recommendation for peers with normal LVEF anticipated to require substantial ventricular pacing.

Wan posed the question of whether it's time for a guideline change in the wake of OptimPacing.

"I do think that with the advent of septal left bundle pacing, definitely a lot of electrophysiologists are comfortable with the procedure," she added.

"I think that most of us are using left bundle branch area pacing as the default option," said press conference moderator Cara Pellegrini, MD, of the University of California San Francisco and VA San Francisco. "The rare times that you may still use right atrial right ventricular apical pacing might be if you were struggling with a left bundle area pacing lead and your patient was particularly sick, and you were just trying to do kind of the fastest, most expedient option."

Wan emphasized patient selection and noted that it is also unclear if people with infiltrative heart disease (e.g. amyloidosis) get the same effects from septal LBBP or RVP in someone with a normal heart.

Zou and colleagues conducted the randomized trial in China, Europe, and the U.S. from 2021-2025. The study population consisted of people with an indication for permanent pacemakers with a high ventricular pacing burden, LVEF >35%, and New York Heart Association class I-III symptoms.

Among exclusion criteria were candidates for an implantable cardioverter-defibrillator, cardiac resynchronization therapy (CRT), or CRT-defibrillator therapy; and people with LVEF 36-50% who were willing to receive biventricular pacing.

The open-label trial had 702 patients randomized and 685 included in the final analysis. The two groups shared balanced baseline characteristics. Mean age was 68.4 years and 57.5% were men. Mean LVEF was 63%, and mean QRS duration about 115 msec. The indication for permanent pacing was atrial fibrillation with a slow ventricular rate in 12.7% of the cohort.

Pacing-induced cardiomyopathy was defined as a 10% or larger drop in LVEF and resultant LVEF ≤50% without alternative causes of cardiomyopathy identified. Heart failure hospitalization covered hospital admissions for more than 24 hours with worsening symptoms of heart failure and treatment with IV diuretics or inotropic medications.

LBBP was successfully implanted in 96.8% of patients; left bundle branch capture was confirmed in 87.6%.

The ventricular pacing burden was >90% in both groups.

Left ventricular end-diastolic and end-systolic volumes were lower with LBBP; LVEF was higher with LBBP.

R-wave sensing and pacing impedance and threshold remained stable in both groups. Left bundle branch capture threshold also remained low and stable, per Zou's report.

Key limitations of OptimPacing include its early termination, which may have led to an overestimation of treatment effects, and the low representation of people with reduced LVEF.

来源:MedPage Today · medpagetoday.com